Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Object Pharma Logo
Object Pharma CB Rank
310149
Heat Score
60
Object Pharma is a develops botulinum neurotoxins to address the unmet needs in aesthetic and therapeutic markets.
Founded
obfuscation
Private Aliso Viejo, California, United States11-50 www.objectpharma.com/home
Industrial
Marketing
Therapeutics
Overview

Object Pharma
Heat Score
60

Growth Score
pts
in past quarter
Heat Score 60
7 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
+2 more milestones
See more interactive data and historical milestones on desktop for the best experience

About Object Pharma

CB Rank
310149
Object Pharma is a develops botulinum neurotoxins to address the unmet needs in aesthetic and therapeutic markets.
Founded
obfuscation
Private Aliso Viejo, California, United States11-50 www.objectpharma.com/home
Industrial
Marketing
Therapeutics

Key People

Details

Legal Name OBJECT PHARMA, INC.
Operating Status Active
Company Type For Profit
About the Company
developing botulinum neurotoxins for unmet needs in the aesthetic and therapeutic markets.
Predictions & Insights

Growth Insight

See this Growth Insight
Object Pharma is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction

Products & Services

Botulinum Neurotoxin for Depression Treatment
A botulinum neurotoxin developed to treat depression and other mental health disorders by improving symptoms and reducing reliance on traditional antidepressants.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1 Board Members and Advisors 1 Contacts 9

Employee Profiles

Board Members and Advisors

News

News and Press

News•Apr 1, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$23.6KThis year, Object Pharma is projected to spend $23.6K on IT, according to Aberdeen.

Active Website Tech Count

3Object Pharma is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, IPhone / Mobile Compatible, and  CommonCrawl Top 50m.
Sub-Organizations
Frequently Asked Questions

Where is Object Pharma's headquarters? Object Pharma is located in Aliso Viejo, California, United States.Who are Object Pharma's competitors? Alternatives and possible competitors to Object Pharma may include Galderma, AbbVie, and  Ipsen.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|